Page 26 - SALIK PR REPORT SEPTEMBER 2024

9/10/24, 11:37 AM Salik Strengthens CSR Commitment with Support to Al Jalila Foundation for Childhood Cancer
Salik Strengthens CSR Commitment with Support to

Al Jalila Foundation for Childhood Cancer

The initiative aligns with Dubai Health efforts to elevate the quality of healthcare provided to patients

within its healthcare facilities.'

Dubai, 9 September 2024: Salik Company PJSC (Salik), the exclusive toll gate operator of the Emirate of Dubai,
has donated 200,000AED to Al Jalila Foundation, which leads the Giving mission of Dubai Health, to support the
care of young cancer patients. Coinciding with Childhood Cancer Awareness Month, this contribution underscores

Salik’s commitment to enhancing community wellbeing, particularly in promoting children’s health. The donation
will help fund the treatment of young patients at Dubai Health’s Al Jalila Children’s Hospital, the first children’s
hospital in the UAE.

The donation was presented during a visit to Al Jalila Children’s Hospital where a plaque in honor of Salik’s
generous contribution will be placed on The Giving Wall. A delegation from Salik Company, led by the CEO Ibrahim

Haddad, then visited young patients. The delegation was received by Dr. Abdullah Al Khayat, the CEO of Al Jalila
Children's, Dr. Mohammed Al Awadhi, the Deputy CEO of Al Jalila Children's and Latifa Hospital.

Ibrahim Haddad, Chief Executive Officer of Salik Company PJSC, said, “At Salik, community wellbeing is part of
our DNA, and our Corporate Social Responsibility is not a mere commitment, rather we view it as an essential

investment for a prosperous future. Through our support for this important cause, we aim to create a positive
impact on the lives of young patients, ensuring they receive the exceptional care they deserve. This further
reaffirms Salik’s dedication to securing the health of future generations, laying the foundation for a brighter

tomorrow, and fulfilling our responsibility to the broader community”.
https://www.dubaiprnetwork.com/pr.asp?pr=180967 1/2